{"id":"NCT02592434","sponsor":"Pfizer","briefTitle":"Efficacy Study Of Tofacitinib In Pediatric JIA Population","officialTitle":"EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FOR TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN CHILDREN AND ADOLESCENT SUBJECTS","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-06-10","primaryCompletion":"2019-05-16","completion":"2019-05-16","firstPosted":"2015-10-30","resultsPosted":"2020-02-21","lastUpdate":"2020-04-13"},"enrollment":225,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Juvenile Idiopathic Arthritis"],"interventions":[{"type":"DRUG","name":"CP-690,550 (tofacitinib)","otherNames":["Matching placebo to tofacitinib (same tablet or solution as the active arm)."]},{"type":"OTHER","name":"placebo","otherNames":["Placebo for tofacitinib"]}],"arms":[{"label":"CP-690,550","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Evaluate efficacy, safety and tolerability of tofacitinib in pediatric JIA patients.","primaryOutcome":{"measure":"Double Blind Phase: Percentage of Participants With Disease Flare According to Pediatric Rheumatology Collaborative Study Group/Pediatric Rheumatology International Trials Organization (PRCSG/PRINTO) Disease Flare Criteria at Week 44","timeFrame":"Week 44","effectByArm":[{"arm":"Tofacitinib: Double Blind Phase","deltaMin":29.17,"sd":null},{"arm":"Placebo","deltaMin":52.86,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0031"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":103,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","Israel","Mexico","Poland","Russia","Spain","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["40312101","38298058","34767764"],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=A3921104"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":225},"commonTop":["Upper respiratory tract infection","Disease progression","Headache","Nasopharyngitis","Juvenile idiopathic arthritis"]}}